Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined diuretic therapy in chronic congestive heart failure
2024-519565-21-01Phase 3Authorised
- Sponsor
- Centro Cardiologico Monzino
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metolazone and acetazolamide in heart failure (HF) and chronic heart failure (CHF) (2 arms), sponsored by Centro Cardiologico Monzino. Planned start Mar 2025; status: authorised.
02
Drugs
metolazoneacetazolamide
03
Conditions
heart failure (HF)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2024-519565-21-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519565-21-01.